Anika Therapeutics, Inc.
ANIK
$14.69
-$0.36-2.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -29.92M | -88.00K | -4.51M | -63.00M |
| Total Depreciation and Amortization | -- | 2.19M | 2.06M | 2.06M | 3.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 31.25M | 5.00M | 6.50M | 65.68M |
| Change in Net Operating Assets | -- | 1.49M | -8.04M | -4.18M | -2.61M |
| Cash from Operations | -- | 5.02M | -1.07M | -126.00K | 3.64M |
| Capital Expenditure | -- | -1.22M | -3.40M | -1.81M | -1.84M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -600.00K | -- | -- | -- |
| Cash from Investing | -- | -1.82M | -3.40M | -1.81M | -1.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 464.00K | 23.00K | 335.00K |
| Repurchase of Common Stock | -- | -3.99M | -1.58M | -2.30M | 7.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -3.99M | -1.11M | -2.27M | 342.00K |
| Foreign Exchange rate Adjustments | -- | 337.00K | -224.00K | -31.00K | 76.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -454.00K | -5.81M | -4.24M | 2.22M |
